DoorDash stock dips on year-end slide as markets shut for New Year’s Day — what’s next for DASH

DoorDash stock dips on year-end slide as markets shut for New Year’s Day — what’s next for DASH

NEW YORK, January 1, 2026, 17:00 ET — Market closed

  • DoorDash (DASH) last closed down 0.7% at $226.48 in the final U.S. session of 2025.
  • U.S. stock markets are closed Thursday for New Year’s Day, with trading set to resume Friday. New York Stock Exchange

DoorDash, Inc. shares ended the last trading day of 2025 lower, mirroring a broad pullback that capped the year in thin holiday-week trading.

The move matters because the first trading sessions of 2026 will test whether investors keep trimming higher-growth consumer internet names or rotate back into them as liquidity returns.

For DoorDash, the near-term focus remains demand momentum and cost discipline, two drivers that can swing expectations quickly when the market’s appetite for risk shifts.

DASH finished at $226.48 on Wednesday, down 0.7% from the prior close, with about 2.45 million shares traded, according to market data.

Wall Street’s major indexes also ended the year lower on Wednesday, with the S&P 500 down 0.74%, the Nasdaq off 0.76% and the Dow down 0.63%, Reuters reported. Reuters

“I do not expect that the last few days will have so much bearing on the performance of the next year,” said Giuseppe Sette, co-founder and president of Reflexivity, pointing to profit-taking when liquidity was low. Reuters

The holiday calendar amplified the moves. The NYSE lists New Year’s Day, Thursday, January 1, as a U.S. market holiday. New York Stock Exchange

Separately, DoorDash is heading into 2026 with ongoing scrutiny on how delivery platforms handle pay and tips. New York’s attorney general said the deadline for eligible Dashers to file claims tied to a $16.75 million settlement was December 31, 2025. New York State Attorney General

When markets reopen, traders will be watching whether DASH reclaims the $230 area quickly or stays pinned below it as investors reassess growth exposure after the year-end pullback.

Macro data is also in view. The U.S. Employment Situation report for December 2025 is scheduled for Friday, January 9, at 8:30 a.m. ET, a release that can move rate expectations and consumer-spending sentiment. Bureau of Labor Statistics

On the policy front, the Federal Reserve’s 2026 calendar shows the next FOMC meeting scheduled for January 27–28. Federal Reserve

DoorDash has not announced a date for its next earnings release; Nasdaq’s earnings page shows an estimated report date of February 10, 2026, based on an algorithm using historical reporting patterns. Nasdaq

Technically, DASH is coming into 2026 after trading Wednesday between $226.08 and $228.50, leaving that band as an early reference point for support and resistance as volume returns.

Stock Market Today

  • Biren Technology surges 82% in Hong Kong debut after $717 million IPO
    January 1, 2026, 9:01 PM EST. Shanghai Biren Technology, an AI chip designer, surged about 82% in its Hong Kong trading debut after raising $717 million in an initial public offering (IPO). The stock opened at HK$35.70, well above the HK$19.60 IPO price, which was the top of the indicative range. Deal data show the IPO's retail portion was subscribed more than 2,300 times, underscoring strong demand from individual investors. The company had seen pre-debut activity in Hong Kong's gray market, a trading proxy before a formal listing, signaling enthusiasm. Biren, backed by chip industry peers, is among AI hardware plays attracting capital as the sector remains hot. The listing proceeds will fund development and scale manufacturing for its next-generation AI accelerators.
Apple stock forecast for 2026: Can AAPL reach $350 as AI questions linger?
Previous Story

Apple stock forecast for 2026: Can AAPL reach $350 as AI questions linger?

Axsome Therapeutics (AXSM) stock jumps after FDA sets April 30 decision for Alzheimer’s agitation drug
Next Story

Axsome Therapeutics (AXSM) stock jumps after FDA sets April 30 decision for Alzheimer’s agitation drug

Go toTop